GI Innovation said Wednesday that its Japanese partner Maruho plans to dose the first patient in a phase 2 trial of allergy ...

Despite major advances in psoriasis treatment, many Korean patients remain undertreated and face social stigma, prompting ...

Less than two weeks after winning U.S. approval for lirafugratinib, HLB is moving the targeted bile duct cancer drug through ...

Children as young as two with Covid-19 can now be treated with Celltrion's intravenous Avtozma in the U.S., following an FDA ...

A police raid on Ajou University Hospital’s pediatric emergency center drew scrutiny at a parliamentary audit Wednesday, ...

GC WellBeing has partnered with obesity treatment specialist 365mc to build clinical evidence and develop treatment protocols ...

Park Jong-hoon, a professor of orthopedic surgery at Korea University College of Medicine, is making his second bid for the ...

Lotte Biologics has secured a manufacturing contract with global biotech company Alvotech to produce drug substances for ...

Hanyang University Myongji Hospital has partnered with U.S.-based physical AI company Lavoro AI to jointly test and develop ...

Korea's proposed 2027 budget allocates no funding to purchase tuberculosis (TB) drugs that the government has directly ...

ST Pharm said Tuesday that its investigational HIV-1 drug candidate STP0404 was generally well tolerated in a U.S. phase 2a ...

Korean biotech company Optipharm is accelerating its expansion into xenotransplantation using genetically modified pigs and ...